Simpson Thacher Represents the Initial Purchasers in $500 Million Senior Notes Offering by Takeda
09.11.17
This is only gets display when printing
Simpson Thacher recently represented the initial purchasers in the offering by Takeda Pharmaceuticals Company Limited of $500 million aggregate principal amount of its senior fixed rate notes due 2022. The notes were sold to international investors outside of Japan in reliance on Rule 144A and Regulation S.
Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Nomura Securities International, Inc. acted as the initial purchasers for the offering.
Takeda Pharmaceuticals Company Limited was the largest pharmaceutical company in Japan for the fiscal year ended March 31, 2017 in terms of consolidated pharmaceutical sales and is one of the global leaders of the industry.
The Simpson Thacher team for the offering included Alan Cannon, David Snowden and Daniel Hulme (Capital Markets); Jonathan Cantor and Morgan Otway (Tax); and Jennie Getsin (Blue Sky).